The new oral drug “Monoprevir” is expected to be launched in China this Friday
Read Time:35 Second
Liu Yong, a representative of Shanghai People’s Congress and president of Sinopharm Holdings, said at the site of the two sessions in Shanghai that the world’s first approved oral new coronavirus drug, monoprevir capsules, which is represented by Sinopharm, has passed the drug inspection for the first import today and is expected to be listed in China this Friday. Xiao Cai Note: On December 30, the State Drug Administration approved the import registration of Mercer’s new coronavirus treatment drug, Monoprevir capsules, with conditions. The drug is an oral small-molecule neocoronavirus treatment for the treatment of adults with mild to moderate novel coronavirus infection (COVID-19) with high risk factors for progression to severe disease.
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %
0
0
Average Rating